MENA PV Landscape – Key Updates & Inspection Trends

Timely insights on the evolving Pharmacovigilance landscape in the MENA region.

In this episode of Biomapas Insights, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, speaks with Mina Awad, a GxP Auditor, Inspector, and PV expert with over 17 years in the pharmaceutical industry. Based in the United Arab Emirates (UAE) and originally from Egypt, Mina shares timely insights on the evolving Pharmacovigilance landscape in the Middle East and North Africa (MENA) region.

They will discuss:

  • 2025 PV updates in the UAE, Kuwait, and Lebanon
  • UAE GVP changes and the role of the new Emirati Drug Establishment (EDE)
  • Increasing activity from local Health Authorities
  • Inspection trends across UAE, Saudi Arabia, and Egypt
  • Common findings: PV agreements and QPPV qualifications
  • Managing local distributors and business partners
Choosing the Right QPPV Partner for EU and Global Compliance

Choosing the Right QPPV Partner for EU and Global Compliance

Pharmacovigilance outsourcing has become crucial for biotech companies to remain compliant and safeguard patients. When you bring a drug to market in Europe or globally, your Qualified Person for Pharmacovigilance (QPPV) serves as your first line of defense. The right...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information